Literature DB >> 22902881

Styloid-carotid artery syndrome treated surgically with Piezosurgery: a case report and literature review.

Eike Hoffmann1, Christian Räder, Hendrik Fuhrmann, Peter Maurer.   

Abstract

Styloid-carotid artery syndrome was first described by Eagle and is associated with cervical and facial pain caused by head movement resulting from mechanical compression of the carotid nerve plexus due to an elongated styloid process. The case of a 49-year-old man with persistent cervical pain, neurological symptoms and an elongated styloid process of 7.5 cm is reported here; this patient was successfully treated using Piezosurgery. In addition, a literature review is included.
Copyright © 2012 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22902881     DOI: 10.1016/j.jcms.2012.07.004

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  5 in total

1.  Length of the ossified stylohyoid complex and Eagle syndrome.

Authors:  Constantino Ledesma-Montes; Juan Carlos Hernández-Guerrero; María Dolores Jiménez-Farfán
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-09       Impact factor: 2.503

2.  Eagle syndrome.

Authors:  Akira Baba; Yumi Okuyama; Hiroya Ojiri; Tsuneya Nakajima
Journal:  Clin Case Rep       Date:  2017-01-17

3.  Diagnostic and therapeutic dilemma in orofacial pain: A rare case of bilateral Eagle syndrome.

Authors:  Umesh Pradhan; Tika Ram Adhikari
Journal:  SAGE Open Med Case Rep       Date:  2022-08-06

4.  Eagle's syndrome-A non-perceived differential diagnosis of temporomandibular disorder.

Authors:  P Thoenissen; G Bittermann; R Schmelzeisen; T Oshima; T Fretwurst
Journal:  Int J Surg Case Rep       Date:  2015-08-28

5.  The Use of Cone Beam CT(CBCT) in Differentiation of True from Mimicking Eagle's Syndrome.

Authors:  Miloš Tijanić; Nikola Burić; Kristina Burić
Journal:  Int J Environ Res Public Health       Date:  2020-08-05       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.